Completed
The number of genome-based diagnostic tests that have the potential to predict onset of disease or direct drug therapy has steadily increased as improved gene-disease relationships have been identified. However, few have been adopted for use in a health care setting. Given the current challenges, this workshop focused on identifying potential solutions in reimbursement policy, regulatory policy, and generating evidence of clinical utility to advance the development of clinically useful genomics-based diagnostic tests.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.
About
Get in touch
Our People